Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Multicenter Study

Clinical Trial, Phase II

Clinical Trial, Phase I

Clinical Trial

Clinical Trial, Phase III

Comparative Study

Review

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Research Support, N.I.H., Extramural

Observational Study

Publication Year

From

Quick links

Individual year

2024

2023

2022

2021

2018

2017

2016

2015

2014

2012

2011

2010

2009

2008

2006

2005

2004

2003

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Vaccines, Conjugate""[mesh_terms]

36 Results

Searching titles within these results

Multiple antigen presenting system (MAPS): state of the art and potential applications.

Richard Malley, Ying-Jie Lu, Shite Sebastian, Fan Zhang, David O Willer

Expert review of vaccines 2024;23(1):196-204

Free Full Text

Abstract

Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, Bangladesh.

Deok Ryun Kim, Jerome H Kim, Birkneh Tilahun Tadesse, Farhana Khanam, Faisal Ahmmed, Justin Im, Md Taufiqul Islam, Sophie S Y Kang, Xinxue Liu, Fahima Chowdhury, Tasnuva Ahmed, Asma Binte Aziz, Masuma Hoque, Juyeon Park, Gideok Pak, Khalequ Zaman, Ashraful Islam Khan, Andrew J Pollard, Florian Marks, Firdausi Qadri, John D Clemens

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022;75(10):1681-1687

Free Full Text

Abstract

Vitamin A supplements are well tolerated with the pentavalent vaccine.

Sam Newton, Seth Owusu-Agyei, Suzanne Filteau, Thomas Gyan, Betty R Kirkwood

Vaccine 2009;26(51):6608-13

Full Text

Abstract

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.

Arturo Abdelnour, Peter E Silas, Marta Raquel Valdés Lamas, Carlos Fernándo Grazioso Aragón, Nan-Chang Chiu, Cheng-Hsun Chiu, Teobaldo Herrera Acuña, Tirza De León Castrejón, Allen Izu, Tatjana Odrljin, Igor Smolenov, Matthew Hohenboken, Peter M Dull

Vaccine 2014;32(8):965-72

Full Text

Abstract

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.

Lisa A Jackson, Robert M Jacobson, Keith S Reisinger, Alessandra Anemona, Lisa E Danzig, Peter M Dull

The Pediatric infectious disease journal 2009;28(2):86-91

Full Text

Abstract

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.

Emilio Siena, Francesca Schiavetti, Erica Borgogni, Marianna Taccone, Elisa Faenzi, Michela Brazzoli, Susanna Aprea, Monia Bardelli, Gianfranco Volpini, Francesca Buricchi, Chiara Sammicheli, Simona Tavarini, Viviane Bechtold, Christoph J Blohmke, Dario Cardamone, Carlo De Intinis, Antonio Gonzalez-Lopez, Derek T O'Hagan, Sandra Nuti, Claudia Seidl, Arnaud M Didierlaurent, Sylvie Bertholet, Ugo D'Oro, Duccio Medini, Oretta Finco

Vaccine 2023;41(3):724-734

Free Full Text

Abstract

Developing a vaccine against aspergillosis.

David A Stevens, Karl V Clemons, Min Liu

Medical mycology 2012;49 Suppl 1():S170-6

Full Text

Abstract

Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.

Maria Rosario Capeding, Edison Alberto, Arijit Sil, Tarun Saluja, Samuel Teshome, Deok Ryun Kim, Ju Yeon Park, Jae Seung Yang, Suchada Chinaworapong, Jiwook Park, Sue-Kyoung Jo, Yun Chon, Seon-Young Yang, Dong Soo Ham, Ji Hwa Ryu, Julia Lynch, Jerome H Kim, Hun Kim, Jean-Louis Excler, T Anh Wartel, Sushant Sahastrabuddhe

Vaccine 2021;38(28):4476-4483

Free Full Text

Abstract

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.

Jacek Wysocki, Jerzy Brzostek, Henryk Szymański, Bogusław Tetiurka, Ewa Toporowska-Kowalska, Krystyna Wasowska-Królikowska, Denise A Sarkozy, Peter C Giardina, William C Gruber, Emilio A Emini, Daniel A Scott

Vaccine 2015;33(14):1719-25

Full Text

Abstract

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.

Judith Absalon, Nathan Segall, Stan L Block, Kimberly J Center, Ingrid L Scully, Peter C Giardina, James Peterson, Wendy J Watson, William C Gruber, Kathrin U Jansen, Yahong Peng, Samantha Munson, Danka Pavliakova, Daniel A Scott, Annaliesa S Anderson

The Lancet. Infectious diseases 2021;21(2):263-274

Free Full Text

Abstract

Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.

Güler Kanra, Simonetta Viviani, Kadriye Yurdakök, Elif Ozmert, Alessandra Anemona, Songül Yalçin, Okan Demiralp, Nihan Bilgili, Ates Kara, Ali Bülent Cengiz, Belgin Mutlu, Alexandra Baldini, Elisa Marchetti, Audino Podda

Pediatrics international : official journal of the Japan Pediatric Society 2003;45(3):314-8

Full Text

Abstract

A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older.

M E Hanson, D Johnson, K Nguyen, P Sauer, J Clark, J Wassil, M Sisti, J Fairman, B Rankin, S Bennett, T-S Migone, A Paschenko, S Iki, J K Simon

Vaccine 2024;42(25):126124

Free Full Text

Abstract

Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial.

Marilla G Lucero, Taneli Puumalainen, Juanita M Ugpo, Gail Williams, Helena Käyhty, Hanna Nohynek

The Journal of infectious diseases 2004;189(11):2077-84

Full Text

Abstract

Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.

Maria Deloria-Knoll, Mark Steinhoff, Richard D Semba, Kenrad Nelson, David Vlahov, Curtis L Meinert

Vaccine 2006;24(10):1670-9

Full Text

Abstract

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.

Dorothee M Kieninger, Kathrin Kueper, Katrin Steul, Christine Juergens, Norbert Ahlers, Sherryl Baker, Kathrin U Jansen, Carmel Devlin, William C Gruber, Emilio A Emini, Daniel A Scott

Vaccine 2010;28(25):4192-203

Full Text

Abstract

Results: 1 – 15 / 36

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Vaccines, Conjugate""[mesh_terms]

Multiple antigen presenting system (MAPS): state of the art and potential applications.

Prevention of Typhoid by Vi Conjugate Vaccine and Achievable Improvements in Household Water, Sanitation, and Hygiene: Evidence From a Cluster-Randomized Trial in Dhaka, Bangladesh.

Vitamin A supplements are well tolerated with the pentavalent vaccine.

Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents.

Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response.

Developing a vaccine against aspergillosis.

Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: A preliminary report.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial.

Effect of aluminum adjuvants on safety and immunogenicity of Haemophilus influenzae type b-CRM197 conjugate vaccine.

A phase 2, randomized, blinded, dose-finding, controlled clinical trial to evaluate the safety, tolerability, and immunogenicity of a 24-valent pneumococcal conjugate vaccine (VAX-24) in healthy adults 65 years and older.

Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial.

Effect of zinc and vitamin A supplementation on antibody responses to a pneumococcal conjugate vaccine in HIV-positive injection drug users: a randomized trial.

Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany.

Results for
""Vaccines, Conjugate""[mesh_terms]